4SC AG

Biotechnology

  • Short facts

    • Research & Development
  • Year founded 1997
  • 47 Employees (site)
  • Turnover: <5m EUR

Products/services: 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 47 employees as of 30 June 2019 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A14KL72). 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The... read more 

Basic data

Company

4SC AG

Street

Frauenhoferstr. 22

PC / City

82152 Planegg-Martinsried

County

Upper Bavaria

Phone

+49 89 700763-0

Fax

+49 89 700763-29

Language skills

English, German

Contact person

Management: Dr. Jason Loveridge (Mr.)

Profile/competences

Core competencies

Drug production
Clinical studies

Key sectors / sub-sectors

  • Biotechnology: Bioinformatics and cheminformatics
  • Biotechnology: Preclinical development
  • Biotechnology: Therapeutic drug development

NACE industries

  • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
  • Manufacture of pharmaceutical preparations 21.2
  • Manufacture of pharmaceutical preparations 21.20
  • Scientific research and development 72

Certifications / awards

not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available